(19)
(11) EP 3 808 371 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
24.01.2024 Bulletin 2024/04

(45) Mention of the grant of the patent:
22.11.2023 Bulletin 2023/47

(21) Application number: 18922562.6

(22) Date of filing: 30.10.2018
(51) International Patent Classification (IPC): 
A61K 9/08(2006.01)
A61K 38/18(2006.01)
A61P 27/04(2006.01)
A61K 31/728(2006.01)
A61P 27/02(2006.01)
 A61K 38/47(2006.01)
A61K 31/7012(2006.01)
A61K 9/00(2006.01)
A61K 47/02(2006.01)
A61P 31/02(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 38/47; A61P 27/04; A61P 31/02; A61K 47/02; A61P 27/02; A61K 31/728; A61K 9/08; A61K 31/7012; C12Y 302/01017; A61K 38/1808; A61K 9/0048
(86) International application number:
PCT/CN2018/112517
(87) International publication number:
WO 2019/237633 (19.12.2019 Gazette 2019/51)

(54)

NOVEL ARTIFICIAL TEARS CONTAINING RECOMBINANT HUMAN LYSOZYME AND RECOMBINANT HUMAN EPIDERMAL GROWTH FACTOR

NEUARTIGE KÜNSTLICHE TRÄNEN MIT REKOMBINANTEM HUMANEM LYSOZYM UND REKOMBINANTEM MENSCHLICHEM EPIDERMALEM WACHSTUMSFAKTOR

NOUVELLES LARMES ARTIFICIELLES CONTENANT UN LYSOZYME HUMAIN RECOMBINANT ET UN FACTEUR DE CROISSANCE ÉPIDERMIQUE HUMAIN RECOMBINANT

(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 14.06.2018 CN 201810613195

(43) Date of publication of application:
21.04.2021 Bulletin 2021/16

(73) Proprietor: Shaanxi Huikang Bio-Tech Co., Ltd.
Xi'an City, Shaanxi Province 710077 (CN)

(72) Inventors:
  • SHI, Jin
    Xi'an City, Shaanxi Province, 710077 (CN)
  • HOU, Zengmiao
    Xi'an City, Shaanxi Province, 710077 (CN)
  • GAO, En
    Xi'an City, Shaanxi Province, 710077 (CN)
  • LI, Xiaoying
    Xi'an City, Shaanxi Province, 710077 (CN)
  • PANG, Rongrong
    Xi'an City, Shaanxi Province, 710077 (CN)
  • YANG, Xiaolin
    Xi'an City, Shaanxi Province, 710077 (CN)
  • ZHAO, Jinli
    Xi'an City, Shaanxi Province, 710077 (CN)

(74) Representative: Habermann, Hruschka & Schnabel 
Patentanwälte Montgelasstraße 2
81679 München
81679 München (DE)


(56) References cited: : 
CN-A- 102 188 695
US-A1- 2007 280 924
US-A1- 2017 246 218
 CN-A- 102 552 889
US-A1- 2008 213 188
US-B2- 7 655 698
   
  • Anonymous: "Sodium hyaluronate | 9067-32-7", Chemical Book, 1 January 2017 (2017-01-01), pages 1-6, XP055753401, Retrieved from the Internet: URL:https://www.chemicalbook.com/ChemicalP roductProperty_EN_CB4176691.htm [retrieved on 2020-11-24]
  • SAAEHA RAUZ ET AL: "Serum eye drops, amniotic membrane and limbal epithelial stem cells-tools in the treatment of ocular surface disease", CELL AND TISSUE BANKING, KLUWER ACADEMIC PUBLISHERS, DO, vol. 11, no. 1, 22 April 2009 (2009-04-22) , pages 13-27, XP019767483, ISSN: 1573-6814
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).